The Predictive And Presymptomatic Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Predictive And Presymptomatic Testing Market?
The market size for predictive and presymptomatic testing has experienced rapid expansion in recent years. The market, valued at $5.24 billion in 2024, is projected to increase to $5.78 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Predictive And Presymptomatic Testing Industry?
The Predictive and Presymptomatic Testing Global Market Report anticipates that by 2029, the market size will reach $8.47 billion, expanding at a compound annual growth rate (CAGR) of 10.1%.
Download Your Free Sample of the 2025 Predictive And Presymptomatic Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Predictive And Presymptomatic Testing Market?
The key drivers in the predictive and presymptomatic testing market are:
• Rising demand for early disease detection
• Increased investment in biotechnology and genomics
• High demand for non-invasive testing methods
• Growth in geriatric population and precision medicine initiatives
Global Market Segmentation: Identifying Major Predictive And Presymptomatic Testing Industry Segments
The predictive and presymptomatic testing market covered in this report is segmented –
1) By Test Type: Predictive Testing, Presymptomatic Testing
2) By Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Other Applications
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Predictive Testing: Genetic Testing for Inherited Conditions, Cancer Risk Prediction, Cardiovascular Disease Prediction, Neurodegenerative Disease Risk Prediction, Genetic Screening for Autosomal Dominant Disorders, Prenatal Predictive Testing, Pharmacogenomic Testing
2) By Presymptomatic Testing: Huntington’s Disease Testing, Hereditary Cancer Risk Testing, Cystic Fibrosis Presymptomatic Testing, Early-Onset Alzheimer’s Disease Testing, Carrier Screening for Genetic Conditions, Testing for Early Signs of Neurodegenerative Diseases, Presymptomatic Genetic Testing for Familial Diseases
Pre-order the 2025 Predictive And Presymptomatic Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Predictive And Presymptomatic Testing Market?
The key trends in the predictive and presymptomatic testing market are:
• Personalized medicine is becoming a significant trend in the presymptomatic and predictive testing market.
• The adoption of home testing kits is shaping the future growth of the market.
• The integration of big data and genomics in predictive testing is an emerging trend.
• The application of predictive testing in the field of drug development is becoming more prevalent.
Who Are the Top Competitors & Leading Players in the Predictive And Presymptomatic Testing Market?
Major players in the predictive and presymptomatic testing market are:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Mayo Clinic
• Quest Diagnostics Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Peter MacCallum Cancer Centre
• Myriad Genetics Inc.
• SomaLogic Inc.
• Siteman Cancer Center
• Dante Labs S.R.L.
• Mapmygenome
• Manipal Health Enterprises
• Gene Vision
• Reliance Diagnostic
• GenepoweRx
• Personal Genomics
• Apollo Hospitals Enterprise Limited
• Cardio Diagnostics Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the predictive and presymptomatic testing market in 2024
